AZN — AstraZeneca Share News

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Market Cap
£198.21bn
Enterprise Value
£217.54bn
Revenue
$54.07bn

REG - AstraZeneca PLC - New Sustainability Committee of the Board
23/09/2021 07:00Announcement
REG - AstraZeneca PLC - Board Committee Change
23/09/2021 07:00Announcement
REG - AstraZeneca PLC - AstraZeneca $360m Irish manufacturing investment
21/09/2021 07:00Announcement
REG - AstraZeneca PLC - Enhertu reduced risk of disease progression by 72%
20/09/2021 07:00Announcement
REG - AstraZeneca PLC - Imfinzi improves survival in NSCLC in POSEIDON
09/09/2021 16:00Announcement
REG - AstraZeneca PLC - PT027 PhIII asthma trials met primary endpoints
09/09/2021 07:05Announcement
REG - AstraZeneca PLC - Ultomiris approved in EU for children with PNH
03/09/2021 07:05Announcement
REG - Schiehallion Fund Schiehallion - MNTN Schiehallion - MNTC - Directorate Change
02/09/2021 17:35Announcement
REG - AstraZeneca PLC - Total Voting Rights
01/09/2021 15:05Announcement
REG - AstraZeneca PLC - Forxiga approved in Japan for CKD
26/08/2021 07:05Announcement
REG - AstraZeneca PLC - ALXN1840 Wilson Phase III met primary endpoint
26/08/2021 07:00Announcement
REG - BMO Cap & Inc InvTst - Portfolio Update
23/08/2021 13:38Announcement
REG - AstraZeneca PLC - AZD7442 prophylaxis trial met primary endpoint
20/08/2021 07:05Announcement
REG - AstraZeneca PLC - Update on Ultomiris Phase III ALS trial
20/08/2021 07:05Announcement
REG - AstraZeneca PLC - Director/PDMR Shareholding
16/08/2021 15:00Announcement
REG - AstraZeneca PLC - Update on US review of roxadustat
11/08/2021 14:40Announcement
REG - AstraZeneca PLC - Enhertu head-to-head trial meets primary endpoint
09/08/2021 07:05Announcement
REG - AstraZeneca PLC - Forxiga approved in the EU for CKD
09/08/2021 07:05Announcement
REG - AstraZeneca PLC - Total Voting Rights
02/08/2021 15:05Announcement
REG - AstraZeneca PLC - Saphnelo approved in the US for SLE
02/08/2021 07:05Announcement